NCT02799160 (Paracentesis) is a clinical trial in Paracentesis, sponsored by Charite University, Berlin, Germany.

Who is sponsoring NCT02799160?

NCT02799160 is sponsored by Charite University, Berlin, Germany.

What condition does NCT02799160 study?

NCT02799160 studies Paracentesis.

Is NCT02799160 still recruiting?

NCT02799160 is currently status unknown. Last updated 13 February 2024.

Last reviewed 2024-02-13 · How we verify

NCT02799160: Paracentesis

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical, Biochemical and Haemodynamic Effects of Large-volume Paracentesis (LVP) in Inflammatory Situations

Status unknown Last updated 13 February 2024

What this trial tests

trial in Paracentesis in 22 participants. Status unknown.

Timeline

1 October 2016

Primary endpoint
29 November 2017

1 June 2024

Quick facts

Lead sponsor	Charite University, Berlin, Germany
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	22
Start date	1 October 2016
Primary completion	29 November 2017
Estimated completion	1 June 2024
Sites	1 location across Germany

Conditions studied

Paracentesis — all drugs for Paracentesis →

Sponsor

Charite University, Berlin, Germany

Who can join

Adults 18 to 70, any sex, with Paracentesis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This observational study evaluates the clinical, biochemical and haemodynamic effects of large-volume paracentesis (LVP) in 50 patients with and without signs of inflammation

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Paracentesis

Currently open trials in the same condition.

NCT05964439 — Augmented Reality Ultrasound Guidance · NA · recruiting
NCT03506893 — Medical-economic Evaluation of the Care of Refractory Ascites by Implantation of Alfapump® Device in Cirrhotic Patients · NA · recruiting

Other Charite University, Berlin, Germany trials

Trials by the same sponsor.

NCT07486167 — Influence of Lung Volume Optimization Maneuver on Cardiac Output and Lung Compliance in Ventilated Children With Congeni · Phase 1, PHASE2 · not yet recruiting
NCT07476729 — International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020) · Phase 3 · not yet recruiting
NCT07503054 — Ovarian Cancer Screening and AI · NA · not yet recruiting
NCT07529197 — Observational Study on Immunoadsorption (IA) in Patients With Autoantibody-Positive Post-Infectious ME/CFS · recruiting
NCT07388693 — Feasibility of Integrating Olfactory Stimuli Into Virtual Reality Cue Exposure for Patients With Alcohol Dependence · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02799160 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Charite University, Berlin, Germany
Last refreshed: 13 February 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02799160.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing